Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido

Background: Klebsiella pneumoniae is a pathogenic bacterium frequently isolated from nosocomial samples, specially the subspecie pneumoniae, with extensive antibiotic resistance profiles, including third generation cephalosporins, aminoglycosides and quinolones. This is specially true for those strains producing extended spectrum beta lactamases (ESBL). Aim: To investigate the susceptibility to gentamicin, amikacin and ciprofloxacin and the presence of some aminoglycoside modifying enzyme (AMEs) among nosocomial strains of K pneumoniae subspecie pneumoniae producing ESBL. Material and methods: The antibiotic resistant patterns and the level of resistance (minimal inhibitory concentration, MIC) of 100 strains, isolated from several hospitals of different Chilean cities, were determined. The presence of some aminoglycosides modifying enzyme (AMEs) was investigated by PCR. Results: Sixty five percent of strains were resistant to gentamicin, 47% were resistant to amikacin and 29% were resistant to ciprofloxacin. The most frequent AMEs genes detected were the aac(6')-Ib gene (6'-N-Acetyltransferase type Ib enzyme) in 69% of strains, conferring resistance to amikacin, kanamycin, tobramycin, and neomycin, and the gene aac(3)-IIa (3-Acetyltransferase type 3-IIa enzyme), in 36% of strains, conferring resistance to gentamicin. Conclusions: Among nosocomial strains of K pneumoniae subspecie pneumoniae isolated from Chilean hospitals, there is an association between the production of ESBL and the resistance to others antimicrobial agents, especially aminoglycosides. Nevertheless, 71% of isolates are susceptible to ciprofloxacin (Rev Méd Chile 2004; 132: 1173-8)

Saved in:
Bibliographic Details
Main Authors: Díaz Q,Patricia, Bello T,Helia, Domínguez Y,Mariana, Trabal F,Natalia, Mella M,Sergio, Zemelman Z,Raúl, González R,Gerardo
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2004
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004001000003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872004001000003
record_format ojs
spelling oai:scielo:S0034-988720040010000032004-12-15Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendidoDíaz Q,PatriciaBello T,HeliaDomínguez Y,MarianaTrabal F,NataliaMella M,SergioZemelman Z,RaúlGonzález R,Gerardo Aminoglycosides Antibiotic resistance, bacterial Klebsiella pneumoniae Background: Klebsiella pneumoniae is a pathogenic bacterium frequently isolated from nosocomial samples, specially the subspecie pneumoniae, with extensive antibiotic resistance profiles, including third generation cephalosporins, aminoglycosides and quinolones. This is specially true for those strains producing extended spectrum beta lactamases (ESBL). Aim: To investigate the susceptibility to gentamicin, amikacin and ciprofloxacin and the presence of some aminoglycoside modifying enzyme (AMEs) among nosocomial strains of K pneumoniae subspecie pneumoniae producing ESBL. Material and methods: The antibiotic resistant patterns and the level of resistance (minimal inhibitory concentration, MIC) of 100 strains, isolated from several hospitals of different Chilean cities, were determined. The presence of some aminoglycosides modifying enzyme (AMEs) was investigated by PCR. Results: Sixty five percent of strains were resistant to gentamicin, 47% were resistant to amikacin and 29% were resistant to ciprofloxacin. The most frequent AMEs genes detected were the aac(6')-Ib gene (6'-N-Acetyltransferase type Ib enzyme) in 69% of strains, conferring resistance to amikacin, kanamycin, tobramycin, and neomycin, and the gene aac(3)-IIa (3-Acetyltransferase type 3-IIa enzyme), in 36% of strains, conferring resistance to gentamicin. Conclusions: Among nosocomial strains of K pneumoniae subspecie pneumoniae isolated from Chilean hospitals, there is an association between the production of ESBL and the resistance to others antimicrobial agents, especially aminoglycosides. Nevertheless, 71% of isolates are susceptible to ciprofloxacin (Rev Méd Chile 2004; 132: 1173-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.10 20042004-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004001000003es10.4067/S0034-98872004001000003
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Díaz Q,Patricia
Bello T,Helia
Domínguez Y,Mariana
Trabal F,Natalia
Mella M,Sergio
Zemelman Z,Raúl
González R,Gerardo
spellingShingle Díaz Q,Patricia
Bello T,Helia
Domínguez Y,Mariana
Trabal F,Natalia
Mella M,Sergio
Zemelman Z,Raúl
González R,Gerardo
Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
author_facet Díaz Q,Patricia
Bello T,Helia
Domínguez Y,Mariana
Trabal F,Natalia
Mella M,Sergio
Zemelman Z,Raúl
González R,Gerardo
author_sort Díaz Q,Patricia
title Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
title_short Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
title_full Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
title_fullStr Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
title_full_unstemmed Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
title_sort resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de klebsiella pneumoniae subespecie pneumoniae productoras de ß-lactamasas de espectro extendido
description Background: Klebsiella pneumoniae is a pathogenic bacterium frequently isolated from nosocomial samples, specially the subspecie pneumoniae, with extensive antibiotic resistance profiles, including third generation cephalosporins, aminoglycosides and quinolones. This is specially true for those strains producing extended spectrum beta lactamases (ESBL). Aim: To investigate the susceptibility to gentamicin, amikacin and ciprofloxacin and the presence of some aminoglycoside modifying enzyme (AMEs) among nosocomial strains of K pneumoniae subspecie pneumoniae producing ESBL. Material and methods: The antibiotic resistant patterns and the level of resistance (minimal inhibitory concentration, MIC) of 100 strains, isolated from several hospitals of different Chilean cities, were determined. The presence of some aminoglycosides modifying enzyme (AMEs) was investigated by PCR. Results: Sixty five percent of strains were resistant to gentamicin, 47% were resistant to amikacin and 29% were resistant to ciprofloxacin. The most frequent AMEs genes detected were the aac(6')-Ib gene (6'-N-Acetyltransferase type Ib enzyme) in 69% of strains, conferring resistance to amikacin, kanamycin, tobramycin, and neomycin, and the gene aac(3)-IIa (3-Acetyltransferase type 3-IIa enzyme), in 36% of strains, conferring resistance to gentamicin. Conclusions: Among nosocomial strains of K pneumoniae subspecie pneumoniae isolated from Chilean hospitals, there is an association between the production of ESBL and the resistance to others antimicrobial agents, especially aminoglycosides. Nevertheless, 71% of isolates are susceptible to ciprofloxacin (Rev Méd Chile 2004; 132: 1173-8)
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004001000003
work_keys_str_mv AT diazqpatricia resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT bellothelia resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT dominguezymariana resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT trabalfnatalia resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT mellamsergio resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT zemelmanzraul resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
AT gonzalezrgerardo resistenciaagentamicinaamikacinayciprofloxacinaencepashospitalariasdeklebsiellapneumoniaesubespeciepneumoniaeproductorasdeßlactamasasdeespectroextendido
_version_ 1755988144451223552